VivoSeq
Other

Insulin Resistant

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Insulin Resistant is an early-stage landscape with 0 programs across 1 company. The most active players are KinDex Pharmaceuticals, Inc..

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

18/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

K

KinDex Pharmaceuticals, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

11

clinical trials

Completed8 · 73%
Terminated2 · 18%
Recruiting1 · 9%

Clinical Trials

Trial Activity

11 trials

Melatonin & Metformin on Clinical & Biochemical Parameters in Insulin Resistant PCOS Compared to Metformin
Recruiting·—·N/A·NCT07307677·60 enrolled
Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS
Completed·—·N/A·NCT07472179·60 enrolled
The Vascular Effects of Vildagliptin in Insulin Resistant Individuals
Completed·RRoyal Devon and Exeter NHS Foundation Trust·Phase 3·NCT01122641·15 enrolled
Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance
Completed·YYale University·Phase 4·NCT00667498·28 enrolled
Endogenous Opioid Activity and Affective State in Insulin Resistant Women
Completed·UUniversity of Michigan·Phase 4·NCT02069379·42 enrolled
Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects
Completed·—·N/A·NCT00926016·23 enrolled
Metformin in Insulin Resistant Left Ventricular (LV) Dysfunction (TAYSIDE Trial)
Completed·UUniversity of Dundee·Phase 4·NCT00473876·62 enrolled
Metformin Effect on Brain Function in Insulin Resistant Elderly People
Completed·MMayo Clinic·Phase 2·NCT03733132·40 enrolled
Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects
Completed·KKinDex Pharmaceuticals, Inc.·Phase 2·NCT02444910·9 enrolled
Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant
Terminated·SSemnan University of Medical Sciences·Phase 2·NCT02523898·388 enrolled
Vitamin D Replacement in Insulin Resistant South Asians
Terminated·UUniversity of Leicester·N/A·NCT01385345·3 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)